Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model
about
HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging.Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic ratsEndotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat.Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic ratsMorphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic ratThe HIV-1 transgenic rat model of neuroHIV.Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.Latest trends in drugs of abuse - HIV infection and neuroAIDS.Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic ratIncreased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease.Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.HIV-associated cellular senescence: A contributor to accelerated aging.Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats.Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120.
P2860
Q34050958-96C331C1-3273-4DF2-B40B-B6259654D536Q35218599-3F6E52E2-F2C0-497A-8958-4A054C2F7B6CQ35878203-7D8A29F7-9CD9-4EB6-9688-A475D6C5D271Q35929596-50125ED4-EFE8-483A-9DD8-34CCD0C6B33EQ36109980-999E408C-96A2-4208-9DAB-B47489A29E4CQ36350800-72BC6758-FD9F-4D60-B518-EC2D7902F67EQ36578522-9F4EFAA1-ACE3-4CFC-9537-E78B445F63D3Q36694953-921D3334-594A-4AF8-945B-47FDCD4EE021Q36790759-56B8323A-B2B9-4734-A175-9D214DDC4591Q37132437-04C16AFA-F9E4-4596-9B9D-D326029504E1Q37226913-B1A95192-2AB0-4BFB-8E46-A2BAFB2787C9Q37956171-6A5C1DC9-9295-46B1-9385-D925CDEEC40EQ39054700-1FA12D1C-C815-40C1-9487-E0E52D18A770Q40755393-55530912-5611-4903-B040-866519FF854EQ42127774-D2274DC3-53F2-4690-AE7E-31B94705EA12Q42282888-ED66D245-03B6-4E25-8C0B-A03A528E370B
P2860
Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model
description
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im August 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/08/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/08/01)
@nl
наукова стаття, опублікована в серпні 2007
@uk
مقالة علمية (نشرت في أغسطس 2007)
@ar
name
Expression of the mu opioid re ...... us type 1 transgenic rat model
@ast
Expression of the mu opioid re ...... us type 1 transgenic rat model
@en
Expression of the mu opioid re ...... us type 1 transgenic rat model
@nl
type
label
Expression of the mu opioid re ...... us type 1 transgenic rat model
@ast
Expression of the mu opioid re ...... us type 1 transgenic rat model
@en
Expression of the mu opioid re ...... us type 1 transgenic rat model
@nl
prefLabel
Expression of the mu opioid re ...... us type 1 transgenic rat model
@ast
Expression of the mu opioid re ...... us type 1 transgenic rat model
@en
Expression of the mu opioid re ...... us type 1 transgenic rat model
@nl
P2093
P2860
P356
P1433
P1476
Expression of the mu opioid re ...... us type 1 transgenic rat model
@en
P2093
Jose A. Beltran
Shilpa Swarup
Sulie L. Chang
P2860
P304
P356
10.1128/JVI.00155-07
P577
2007-08-01T00:00:00Z